MITOMYONCT07920562
Role of AMPKalpha2 in Myonuclear Accretion in Mitochondrial Myopathies
StatusNot Yet Recruiting
PhaseNot specified
SponsorHospices Civils de Lyon
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Metabolic dysfunction
Timeframe: Baseline
Arms and interventions
Patients with genetically confirmed mitochondrial cytopathy who have undergone a muscle biopsy and d
In vitro experimentation and sample analysis
Control subjects having undergone orthopedic surgery resulting in discarded surgical tissue Or contr
In vitro experimentation and sample analysis
Other: Analysis of signaling pathway : AMPK
Sites
1 site in 1 country
- Hôpital Neurologique de Lyon Pierre WertheimerBron, France